Delek Group’s Medtronic MDT Stock Holding History

Delek Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-104,115	Closed	-$8.41M	–	256
2018 Q1	$8.41M	Hold	104,115	–	–	0.43%	88
2017 Q4	$8.44M	Buy	+104,115	New	+$8.34M	0.45%	81

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Delek Group's MDT Position: Q2 2018 in Review

Delek Group sold out of Medtronic (MDT) in Q2 2018, closing a stake of 104,115 shares — an estimated $8.41M sold.

Delek Group first reported a position in MDT in Q4 2017 and held it in 2 quarters. The position peaked at $8.44M in Q4 2017. 1,409 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

Delek Group reported no remaining Medtronic position as of Q2 2018 after selling out during the quarter.
Delek Group sold 104,115 Medtronic shares in Q2 2018, an estimated $8.41M.
Delek Group first reported a position in Medtronic in Q4 2017 and held it in 2 quarters.
Delek Group's Medtronic position peaked at $8.44M in Q4 2017.
1,409 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on Delek Group's 13F filing for Q2 2018, filed 9 Aug 2018.